Using 10 years of electronic health record data, researchers at the cancer center found that patients taking GLP-1s (Glucagon-like peptide-1 receptor agonists) was associated with lowered risks for endometrial, ovarian and meningioma cancers
Led by Michael Koch, MD, IU is among the first cancer centers to enroll patients in the study evaluating an implantable device designed to help men regain urinary control following prostate removal surgery.
Read about the implantable device that is improving lives
New research from IU scientists could lead to more effective treatments against one of the deadliest forms of cancer.
IU scientists have identified a new way to weaken pancreatic cancer’s defenses by targeting two key proteins that help the deadly disease resist treatment.
Vera Bradley Foundation for Breast Cancer raises more than $1M for IU breast cancer research, AACR releases Cancer Progress Report 2025, inaugural Outpacing Prostate Cancer event, Indiana Cancer Consortium names new director, Updates from NCCN, upcoming events, member highlights, and more.
